Source:http://linkedlifedata.com/resource/pubmed/id/20979535
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7-8
|
pubmed:dateCreated |
2011-3-23
|
pubmed:abstractText |
Transfection with either hypoxia-inducible factor-1? (HIF-1?) or heme oxygenase-1 (HO-1) gene can induce neovascularization in ischemic tissues. Although expression of transfected HIF-1? gene occurs rapidly, the expressed HIF-1? protein degrades quickly, limiting its therapeutic efficacy. Meanwhile, expressed HO-1 protein does not rapidly undergo degradation, but gene expression occurs a couple of days after transfection, resulting in apoptosis and a delay in angiogenesis in ischemic tissues at the incipient period of HO-1 gene transfection. We hypothesize that combined delivery of HIF-1? and HO-1 gene will enhance antiapoptosis and neovascularization in ischemic tissue compared with HIF-1? or HO-1 single-gene therapy. To test this hypothesis, ischemic mouse hindlimbs were treated with HIF-1? and/or HO-1 gene therapy. The combined gene therapy proved superior to both single-gene therapies, resulting in rapid expression of HIF-1? gene and long-term maintenance of expressed HO-1 protein. The apoptosis in the ischemic region was significantly less, and angiogenic growth factor secretion and angiogenesis were greater in the combined gene therapy than in either of the single-gene therapies. Our results suggest that a combined gene therapy of HIF-1? and HO-1 enhances the transfection of both genes and improves angiogenesis compared with either single-gene therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1937-335X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
915-26
|
pubmed:meshHeading |
pubmed-meshheading:20979535-Animals,
pubmed-meshheading:20979535-Apoptosis,
pubmed-meshheading:20979535-Blotting, Western,
pubmed-meshheading:20979535-Gene Therapy,
pubmed-meshheading:20979535-Heme Oxygenase-1,
pubmed-meshheading:20979535-Hindlimb,
pubmed-meshheading:20979535-Hypoxia-Inducible Factor 1, alpha Subunit,
pubmed-meshheading:20979535-Immunohistochemistry,
pubmed-meshheading:20979535-Ischemia,
pubmed-meshheading:20979535-Mice,
pubmed-meshheading:20979535-Neovascularization, Pathologic,
pubmed-meshheading:20979535-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2011
|
pubmed:articleTitle |
Combined gene therapy with hypoxia-inducible factor-1? and heme oxygenase-1 for therapeutic angiogenesis.
|
pubmed:affiliation |
School of Chemical and Biological Engineering, Seoul National University, Seoul, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|